Anti-GAD antibodies and periodic alternating nystagmus

Abstract

Background: Autoantibodies directed against glutamic acid decarboxylase (GAD-Ab) have recently been described in a few patients with progressive cerebellar ataxia, suggesting an autoimmune physiopathologic mechanism.

Objective: To determine the exact role of GAD-Ab and gamma-aminobutyric acid (GABA)-ergic neurotransmission in the pathogenesis of cerebellar ataxia.

Design: Case report.

Setting: University neurological hospital.

Patient: We report the case of a patient with subacute cerebellar ataxia associated with GAD-Ab showing periodic alternating nystagmus (PAN).

Intervention: Baclofen, a GABAergic medication, was given to the patient.

Main outcome measures: Eye movement recording of spontaneous nystagmus and postrotatory vestibular responses.

Results: Baclofen was effective in suppressing PAN and improving postrotatory vestibular responses but not for improving cerebellar ataxia.

Conclusion: The presence of PAN and the response to baclofen provide a unique opportunity to suggest a direct role of GAD-Ab in cerebellar dysfunction in this patient.